259 related articles for article (PubMed ID: 4154740)
1. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
Salvesen C; Vaksdal K
Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740
[No Abstract] [Full Text] [Related]
2. [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].
Salvesen C; Vaksdal K
Tidsskr Nor Laegeforen; 1973 Aug; 93(24):1699-703. PubMed ID: 4149082
[No Abstract] [Full Text] [Related]
3. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
[No Abstract] [Full Text] [Related]
4. Monthly intermittent chemotherapy of chronic schizophrenic outpatients with pipothiazine palmitate.
Laurent JS; Carle R; Dumais B; Domingue D
Can Psychiatr Assoc J; 1974 Dec; 19(6):583-91. PubMed ID: 4155349
[No Abstract] [Full Text] [Related]
5. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
Salvesen C; Vaksdal K
PDM; 1974; 5-6(9-12;1-8):10-4. PubMed ID: 4156935
[No Abstract] [Full Text] [Related]
6. Dexetimide: an effective drug for the control of extrapyramidal symptoms induced by pipothiazine palmitate.
Dom R; Van Lommel R; Baro F
Acta Psychiatr Scand; 1973; 49(5):563-9. PubMed ID: 4148581
[No Abstract] [Full Text] [Related]
7. Pipotiazine palmitate (19.552 R.P.) in the long-term treatment of chronic psychoses. A controlled trial on in-patients.
Robak OH
Acta Psychiatr Scand Suppl; 1973; 241():83-94. PubMed ID: 4147515
[No Abstract] [Full Text] [Related]
8. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
[No Abstract] [Full Text] [Related]
9. Clinical experience with pipotiazine palmitate (19.552 R.P.) in Nordic countries. Report of a multicentre investigation.
Kristjansen P; Dencker SJ; Elley J; Hakola A; Heshe J; Malm U; Robak OH; Salvesen C; Vaksdal K
Acta Psychiatr Scand Suppl; 1973; 241():51-6. PubMed ID: 4147511
[No Abstract] [Full Text] [Related]
10. Clinical evaluation of pipotiazine palmitate (19.552 R.P.) used on patients in an acute reception ward.
Elley JH; Petersen JH
Acta Psychiatr Scand Suppl; 1973; 241():75-82. PubMed ID: 4147514
[No Abstract] [Full Text] [Related]
11. Clinical experience with 19.552 R.P. in Nordic countries.
Kristjansen P; Dencker SJ; Elley J; Hakola A; Heshe J; Malm U; Robak OH; Salvesen C; Vaksdal K
Acta Psychiatr Scand Suppl; 1973; 246():42-7. PubMed ID: 4148911
[No Abstract] [Full Text] [Related]
12. Uncontrolled study with pipothiazine palmitate.
Jain RC; Ananth JV; Klingner A; Ban TA; Lehmann HE
Int J Clin Pharmacol; 1973 Feb; 7(1):32-6. PubMed ID: 4699381
[No Abstract] [Full Text] [Related]
13. A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.
Dencker SJ; Frankenberg K; Malm U; Zell B
Acta Psychiatr Scand Suppl; 1973; 241():101-18. PubMed ID: 4147508
[No Abstract] [Full Text] [Related]
14. [Clinical experiences with Imagotan].
Iscar G
Arch Neurobiol (Madr); 1972; 35(4):367-74. PubMed ID: 4404658
[No Abstract] [Full Text] [Related]
15. Pilot trials with long-acting pipotiazine injections.
Hakola A
Acta Psychiatr Scand Suppl; 1973; 241():31-42. PubMed ID: 4147509
[No Abstract] [Full Text] [Related]
16. General evaluation of pipotiazine palmitate in hospitalized and open ward patients with functional psychosis.
Salvesen C; Vaksdal K
Acta Psychiatr Scand Suppl; 1973; 241():57-67. PubMed ID: 4147512
[No Abstract] [Full Text] [Related]
17. [Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)].
Bruck J; Guss H
Int Pharmacopsychiatry; 1974; 9(3):152-65. PubMed ID: 4154320
[No Abstract] [Full Text] [Related]
18. Pipotiazine palmitate: an evaluation of a new long acting intramuscular antipsychotic agent in severely ill schizophrenic patients.
Gallant DM; Mielke D; Bishop G; Oelsner T; Guerrero-Figueroa R
Dis Nerv Syst; 1975 Apr; 36(4):193-6. PubMed ID: 1090427
[TBL] [Abstract][Full Text] [Related]
19. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
[No Abstract] [Full Text] [Related]
20. [Problems of use trials of long-acting tranquilizers in acute psychiatric syndromes].
Ropert R; Lévy L; Ropert M
Ann Med Psychol (Paris); 1973 Feb; 2(2):259-67. PubMed ID: 4147917
[No Abstract] [Full Text] [Related]
[Next] [New Search]